At 91, Dr. Gursaran Pran Talwar, a former director at National Institute of Immunology, who has been working on a birth control vaccine for women since close to 44 years, is no alien to this.The vaccine has now received approvals from Drug Controller General of India (DCGI) for Phase I clinical trial. The Indian Council of Medical Research (ICMR) has designed a protocol for this vaccine to be tested on 120 women at All India Institute of Medical Sciences (AIIMS) and Sir Ganga Ram Hospital (SGRH) in New Delhi.
“If it passes through the human phases of clinical trials, it will be the world’s first birth control vaccine, which will temporarily protect women against pregnancy,” Dr. Talwar told. The vaccine is genetically engineered and the technology has been transferred to Biotech company in Hyderabad, which will manufacture it for trial on 120 women subjects, 50 in Phase-I trial and an…
